Sarcomatous Transformation of a Medically Treated Lactotroph Pituitary Neuroendocrine Tumor?

A biphasic neoplasm was found, with a well-defined but focally intermingled PitNET and a high-grade sarcoma, not otherwise specified (Fig. 1). The PitNET was comprised of small epithelioid cell nests with minimal cytoplasm and delicate “salt and pepper” chromatin. Stromal hyalinization was prominent and in combination with the high N/C ratio was consistent with dopamine agonist treatment effects. The sarcomatous component contained anaplastic spindled to epithelioid cells arranged in sheets and fascicles, with pleomorphic nuclei, open chromatin, scattered macronucleoli, and moderate cytoplasm. There were > 20 mitotic figures per 10 high-power fields. The PitNET was reticulin-poor (though the surrounding fibrotic stroma was positive). Extensive intercellular reticulin characterized the sarcomatous component. By immunohistochemistry (Fig. 2), the densely granulated PitNET cells were positive for prolactin and PIT1, but negative for SF1, TPIT, ACTH, growth hormone, TSH, FSH, and LH. The sarcomatous cells were diffusely positive for vimentin and CD34, but negative for all pituitary hormones and transcription factors, cytokeratin, melanocytic, glial, and muscle markers. The Ki-67 labeling index was < 1% in the PitNET, but up to 60% in the sarcomatous component.

The tumor was further characterized by the UCSF500 Next-Generation Sequencing (NGS) cancer panel. Tumor-only sequencing was performed separately on the two components, revealing an overlapping common activating missense mutation in the PDGFRB oncogene in both regions (allele frequency: 8% in PitNET and 60% in sarcoma). No additional alterations were identified in the PitNET, but the sarcomatous component contained an activating missense mutation in PIK3CA, a truncating missense mutation in RECQL4, biallelic homozygous deletion of CDKN2A/CDKN2B, and TERT promoter rearrangement. Chromosomal copy number analysis revealed an aneuploid genome in both components but essentially no overlap in the copy number variants. While the possibility of contamination could not be entirely excluded, it was considered unlikely, as the other sarcoma-associated alterations were not identified in the PitNET sequencing.

留言 (0)

沒有登入
gif